DDInter1886 DDInter1180
Trospium is an antispasmodic agent used to treat the symptoms of overactive bladder, a condition that causes the bladder muscles to contract uncontrollably. An overactive bladder leads to an increased urge to urinate, frequent urination, and sometimes, loss of control over urination. Trospium is manufactured by _Indevus Pharmaceutical Inc._ and was granted FDA approval in 2007.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Trospium {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Mepenzolate
Trospium {u} (Compound) resembles {v} (Compound) Homatropine Methylbromide
Trospium {u} (Compound) binds {v} (Gene) CHRM3
Trospium {u} (Compound) is included by {v} (Pharmacologic Class) Cholinergic Muscarinic Antagonists
Trospium {u} (Compound) causes {v} (Side Effect) Delirium
Trospium {u} may cause a minor interaction that can limit clinical effects when taken with {v} Polythiazide
Trospium {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Botulinum toxin type A
Trospium {u} may lead to a major life threatening interaction when taken with {v} Potassium chloride
Trospium {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Darifenacin
Trospium may cause a moderate interaction that could exacerbate diseases when taken with Mepenzolate
Trospium (Compound) resembles Homatropine Methylbromide (Compound)
Trospium (Compound) binds CHRM3 (Gene)
Trospium (Compound) is included by Cholinergic Muscarinic Antagonists (Pharmacologic Class)
Trospium (Compound) causes Delirium (Side Effect)
Trospium may cause a minor interaction that can limit clinical effects when taken with Polythiazide
Trospium may cause a moderate interaction that could exacerbate diseases when taken with Botulinum toxin type A
Trospium may lead to a major life threatening interaction when taken with Potassium chloride
Trospium (Compound) resembles Darifenacin (Compound) and Trospium may cause a moderate interaction that could exacerbate diseases when taken with Darifenacin